Apellis Pharmaceuticals, Inc. (APLS) Financials
APLS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 1.1 billion | 667.6 million |
| Dec. 31, 2025 | 1.1 billion | 705.1 million |
| Sept. 30, 2025 | 1.1 billion | 657.6 million |
| June 30, 2025 | 821.4 million | 665.1 million |
APLS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -61.0 million | ? |
| Dec. 31, 2025 | -14.0 million | -82.8 million |
| Sept. 30, 2025 | 108.3 million | 28.2 million |
| June 30, 2025 | 4.4 million | 27.2 million |
APLS Net Income
No data available :(
APLS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 406.7 million | 362.2 million | 12.8 million |
| Dec. 31, 2025 | 467.8 million | 373.6 million | 11.9 million |
| Sept. 30, 2025 | 479.2 million | 361.1 million | 20.7 million |
| June 30, 2025 | 371.5 million | 454.0 million | 15.7 million |
APLS Shares Outstanding
APLS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 77.0 million | 124.3 million | - |
| Dec. 31, 2025 | 205000 | 74.2 million | 147.1 million | - |
| Sept. 30, 2025 | 148000 | 68.2 million | 142.7 million | - |
| June 30, 2025 | 49000 | 67.0 million | 130.7 million | - |
APLS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 268.3 million | 40.8 million |
| Dec. 31, 2025 | 199.9 million | 29.7 million |
| Sept. 30, 2025 | 458.6 million | 24.5 million |
| June 30, 2025 | 178.5 million | 14.1 million |
APLS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
APLS
Price: $41.03
52 week price:
Earnings Per Share: 1.07 USD
P/E Ratio: 38.34
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Ebitda: -11.6 millionMarket Capitalization: 5.3 billion